GBP2 Monoclonal antibody

GBP2 Monoclonal Antibody for WB, ELISA
Cat No. 68559-1-Ig

产品说明书

CloneNo. 2D7G4

宿主/亚型

Mouse / IgG1

种属反应性

Human

应用

WB, ELISA

GBP 2, GBP2, GTP binding protein 2, HuGBP 2

缓冲液配方:  PBS and Azide
PBS and Azide
PBS Only
偶联物:  Unconjugated
Unconjugated
规格: 

-/ -


经过测试的应用

Positive WB detected inHT-1376 cells, Saos-2 cells, HepG2 cells, PC-3 cells, A375 cells

推荐稀释比

应用推荐稀释比
Western Blot (WB)WB : 1:5000-1:50000
It is recommended that this reagent should be titrated in each testing system to obtain optimal results.
Sample-dependent, Check data in validation data gallery.

产品信息

68559-1-Ig targets GBP2 in WB, ELISA applications and shows reactivity with Human samples.

经测试应用 WB, ELISA Application Description
经测试反应性 Human
免疫原 GBP2 fusion protein Ag24108 种属同源性预测
宿主/亚型 Mouse / IgG1
抗体类别 Monoclonal
产品类型 Antibody
全称 guanylate binding protein 2, interferon-inducible
别名 GBP 2, GBP2, GTP binding protein 2, HuGBP 2
计算分子量 591 aa, 67 kDa
观测分子量 67 kDa
GenBank蛋白编号BC022272
基因名称 GBP2
Gene ID (NCBI) 2634
RRIDAB_3085261
偶联类型 Unconjugated
形式 Liquid
纯化方式Protein G purification
UNIPROT IDP32456
储存缓冲液 PBS with 0.02% sodium azide and 50% glycerol , pH 7.3
储存条件Store at -20°C. Stable for one year after shipment. Aliquoting is unnecessary for -20oC storage.

背景介绍

GBP2 is a member of the GTPase family and is crucial to host immunity against pathogens. GBP2 is also used as a marker of interferon (IFN) responsiveness, because it is one of the most highly expressed genes after IFN-γ stimulation. Increased GBP2 expression is also associated with a better prognosis in breast cancer and may have a role in T-cell defense against breast cancer. Interestingly, GBP2 expression in NIH/3T3 fibroblasts inhibited Rac activation and matrix metalloproteinase-9 expression, suggesting a possible role for GBP2 in regulating cancer metastasis. The molecular weight of GBP2 is 67 kDa. (PMID: 29072687, 35383115)

实验方案

Product Specific Protocols
WB protocol for GBP2 antibody 68559-1-IgDownload protocol
Standard Protocols
Click here to view our Standard Protocols
Loading...